Latest News

Welcome to the Alfred Research Alliance news hub. To catch up on the news from our Alliance members, please click on the links below:

Paula Fox Melanoma and Cancer Centre

Around the Precinct – 23 June 2022

The precinct celebrated an important milestone this week as building commenced on the Paula Fox Melanoma and Cancer Centre at The Alfred. The state-of-the-art facility is due to be completed in early 2024 and will offer advanced cancer care for patients as well as extending the reach of the precinct’s world-leading clinical trials. This week… Read More

mRNA funding

Around the Precinct – 16 June 2022

This week, three of our members – Alfred Health, Monash University and Baker Heart and Diabetes Institute – have received significant funding for important mRNA projects aiming to improve treatments for muscular dystrophy, metabolic liver disease in infants and cardiovascular disease. The funding is from the state government’s $2 million mRNA Victoria Research Acceleration Fund,… Read More

Monash Central Clinical School

Around the Precinct – 9 June 2022

Clinical trials on the Alfred precinct have received a funding boost this week, with four Monash researchers receiving a total of $13.6 million in the latest round of the NHMRC Clinical Trials and Cohort Studies Scheme. These trials will enable further research into treatments for debilitating conditions such as diabetes and epilepsy, as well as… Read More

Baker Heart and Diabetes Institute

Around the Precinct – 2 June 2022

This week there is a big focus on diabetes and dementia across the precinct. At the Baker Heart and Diabetes Institute, researchers examined Fitbit data from before and during Melbourne’s 2020 lockdown and noticed a concerning drop in physical activity among people with type 2 diabetes. At Monash University’s Central Clinical School, researchers have published… Read More